A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

October 20, 2022

Primary Completion Date

February 28, 2027

Study Completion Date

February 28, 2027

Conditions
Locally Advanced or Metastatic Solid TumorsNSCLCHNSCCMelanomaTNBCEsophageal CancerGastric CancerCervical CancerColorectal CancerUrothelial CarcinomaClear Cell RCCHCC
Interventions
DRUG

RO7502175

RO7502175 will be administered as per the schedules specified in the respective arms.

DRUG

Atezolizumab

Atezolizumab will be administered as per the schedules specified in the respective arms.

DRUG

Pembrolizumab

Pembrolizumab will be administered as per the schedules specified in the respective arms.

Trial Locations (41)

807

RECRUITING

Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City

2010

RECRUITING

Kinghorn Cancer Centre, Darlinghurst

2610

RECRUITING

GasthuisZusters Antwerpen, Wilrijk

2650

RECRUITING

UZ Antwerpen, Edegem

3168

RECRUITING

Monash Health Monash Medical Centre, Clayton

4040

RECRUITING

CHU de Liège, Herstal

6009

RECRUITING

Linear Clinical Research Ltd, Nedlands

10002

RECRUITING

National Taiwan University Hospital, Taipei

17176

RECRUITING

Karolinska Universitetssjukhuset Solna, Stokholm, Solna

28040

RECRUITING

START MADRID_Hospital Universiario Fundacion Jimenez Diaz, Madrid

28041

RECRUITING

Hospital Universitario 12 De Octubre, Madrid

29010

RECRUITING

Hospital Universitario Virgen de la Victoria, Málaga

30322

COMPLETED

Winship Cancer Institute, Atlanta

34232

RECRUITING

Florida Cancer Specialists - Sarasota, Sarasota

37203

RECRUITING

SCRI Oncology Partners, Nashville

38138

RECRUITING

The West Clinic - Memphis (Union Ave), Germantown

40201

RECRUITING

Chung Shan Medical University Hospital, Taichung

46010

RECRUITING

Hospital Clinico Universitario de Valencia, Valencia

48202

RECRUITING

Henry Ford Hospital, Detroit

63110

COMPLETED

Washington University Medical Center, Division of Oncology, St Louis

80045

RECRUITING

University Of Colorado, Aurora

94305

RECRUITING

Stanford University, San Francisco

98229

RECRUITING

South Texas Accelerated Research Therapeutics (START), San Antonio

02215

RECRUITING

Dana Farber Cancer Institute, Boston

08901

RECRUITING

Rutgers Cancer Institute of New Jersey, New Brunswick

V5Z 4E6

RECRUITING

British Columbia Cancer Agency, Vancouver

K1H 8L6

RECRUITING

Ottawa Hospital Regional Cancer Centre, Ottawa

M5G 1Z5

RECRUITING

Princess Margaret Cancer Centre, Toronto

H3T 1E2

RECRUITING

Sir Mortimer B Davis Jewish General Hospital, Montreal

124 62

RECRUITING

University General Hospital ''ATTIKON'' - General Hospital of West Attica H AGIA VARVARA, Chaïdári

564 03

RECRUITING

Papageorgiou General Hospital of Thessaloniki, N. Efkapria-Pavlos Melas

115 27

RECRUITING

Sotiria Thoracic Diseases Hospital of Athens, Athens

1066 CX

RECRUITING

Het Nederlands Kanker Instituut Antoni Van Leeuwenhoek Ziekenhuis, Amsterdam

9713 GZ

RECRUITING

Universitair Medisch Centrum Groningen, Groningen

03080

RECRUITING

Seoul National University Hospital, Seoul

05505

RECRUITING

Asan Medical Center - PPDS, Seoul

06351

RECRUITING

Samsung Medical Center - PPDS, Seoul

120-752

RECRUITING

Severance Hospital Yonsei University Health System - Clinical Trials Center Pharmacy, Seoul

08908

RECRUITING

ICO l?Hospitalet ? Hospital Duran i Reynals, L'Hospitalet de Llobregat

08035

RECRUITING

Instituto de Investigacion Oncologica Vall dHebron (VHIO) - EPON, Barcelona

413 45

RECRUITING

Sahlgrenska Universitetssjukhuset, Gothenburg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY